I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic.

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Two major forms of diabetes exist, type 1 and type 2. Type 1 diabetes is characterized by a complete lack of insulin that leads to an inability of cells ... such as glucagon-like peptide-1 ...

Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...

A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

Glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2 ... is involved in pancreatic islet cell adaptations to stress and beta-cell survival. Peptides. 2017 Sep;95:68-75.

Semaglutide, commonly known as Ozempic, is a glucagon-like peptide 1 (GLP-1 ... and the L-cells in the gut produce and secrete GLP-1, an inhibitory gastrointestinal hormone.

Feb. 5, 2025 /PRNewswire/ -- The American College of Clinical Pharmacology ® (ACCP) published a recent Position Paper entitled "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor ...